Aquestive Therapeutics, Inc.

NASDAQ:AQST

3.52 (USD) • At close December 27, 2024
Bedrijfsnaam Aquestive Therapeutics, Inc.
Symbool AQST
Munteenheid USD
Prijs 3.52
Beurswaarde 320,947,264
Dividendpercentage 0%
52-weken bereik 1.95 - 6.23
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Daniel Barber
Website https://www.aquestive.com

An error occurred while fetching data.

Over Aquestive Therapeutics, Inc.

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and

Vergelijkbare Aandelen

NexImmune, Inc. logo

NexImmune, Inc.

NEXI

0.205 USD

Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc.

ELDN

4.35 USD

Eargo, Inc. logo

Eargo, Inc.

EAR

2.57 USD

Acasti Pharma Inc. logo

Acasti Pharma Inc.

ACST

3.37 USD

Astria Therapeutics, Inc. logo

Astria Therapeutics, Inc.

ATXS

9.15 USD

Zynerba Pharmaceuticals, Inc. logo

Zynerba Pharmaceuticals, Inc.

ZYNE

1.3 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)